Human AP Endonuclease 1: A Potential Marker for the Prediction of Environmental Carcinogenesis Risk

• Published in: Oxidative medicine and cellular longevity Vol. 2014; no. 2014; pp. 1 - 15
• Main Authors: Seo, Youngrok, Sung, Mi-Kyung, Weon, Jong-Il, Kim, Yeo Jin, Kim, Hye Lim, Park, Jae Sung, Chung, Hai Won
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2014; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Amino acids; Animals; Cancer; Carcinogenesis; Carcinogenesis - genetics; Carcinogenesis - metabolism; Crystal structure; Deoxyribonucleic acid; Disease; Disease susceptibility; DNA; DNA repair; DNA-(Apurinic or Apyrimidinic Site) Lyase - genetics; DNA-(Apurinic or Apyrimidinic Site) Lyase - metabolism; Environment; Gene-Environment Interaction; Genetic aspects; Heavy metals; Humans; Mammals; Medical research; Medicine, Experimental; Metals; Nucleases; Properties; Proteins; Review; Risk Factors; Studies; Transcription factors
• ISSN: 1942-0900; 1942-0994
• DOI: 10.1155/2014/730301

Human apurinic/apyrimidinic endonuclease 1 (APE1) functions mainly in DNA repair as an enzyme removing AP sites and in redox signaling as a coactivator of various transcription factors. Based on these multifunctions of APE1 within cells, numerous studies have reported that the alteration of APE1 could be a crucial factor in development of human diseases such as cancer and neurodegeneration. In fact, the study on the combination of an individual’s genetic make-up with environmental factors (gene-environment interaction) is of great importance to understand the development of diseases, especially lethal diseases including cancer. Recent reports have suggested that the human carcinogenic risk following exposure to environmental toxicants is affected by APE1 alterations in terms of gene-environment interactions. In this review, we initially outline the critical APE1 functions in the various intracellular mechanisms including DNA repair and redox regulation and its roles in human diseases. Several findings demonstrate that the change in expression and activity as well as genetic variability of APE1 caused by environmental chemical (e.g., heavy metals and cigarette smoke) and physical carcinogens (ultraviolet and ionizing radiation) is likely associated with various cancers. These enable us to ultimately suggest APE1 as a vital marker for the prediction of environmental carcinogenesis risk.